Compare OLMA & PBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OLMA | PBT |
|---|---|---|
| Founded | 2006 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2020 | N/A |
| Metric | OLMA | PBT |
|---|---|---|
| Price | $15.39 | $20.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $44.89 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 119.6K |
| Earning Date | 03-16-2026 | 03-13-2026 |
| Dividend Yield | N/A | ★ 1.52% |
| EPS Growth | ★ 15.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $347.47 | N/A |
| P/E Ratio | ★ N/A | $57.37 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.86 | $8.01 |
| 52 Week High | $36.26 | $22.71 |
| Indicator | OLMA | PBT |
|---|---|---|
| Relative Strength Index (RSI) | 39.54 | 47.83 |
| Support Level | $13.11 | $17.04 |
| Resistance Level | $27.38 | $20.72 |
| Average True Range (ATR) | 0.99 | 0.99 |
| MACD | 0.30 | -0.08 |
| Stochastic Oscillator | 57.80 | 25.75 |
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.